• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN ABRE VENOUS SELF-EXPANDING STENT SYSTEM; STENT, ILIAC VEIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN ABRE VENOUS SELF-EXPANDING STENT SYSTEM; STENT, ILIAC VEIN Back to Search Results
Catalog Number AB9U10040090
Medical Device Problem Code Migration or Expulsion of Device (1395)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 03/21/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that an abre venous stent was placed to the left renal vein according to the instructions for use.Later that day, the stent was noted to have migrated to the right atrium.Attempts at endovascular retrieval was not successful and patient required sternotomy and cardiopulmonary bypass to remove the stent.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Additional information received: the patient received an abre self-expanding stent for treatment of nutcracker syndrome compression of the left renal vein and pelvic congestion syndrome ¿ patient underwent stent placement in the left renal vein.It was reported that the abre stent was inappropriately sized causing the stent to migrate.Shortly after the procedure, it was discovered that the stent migrated from the left renal vein to the right ventricle of the patient¿s heart.Attempts were made to remove the stent endoscopically but was unsuccessful.Later that day the patient underwent open heart surgery to remove the stent that had migrated, and the patient has a large scar on their chest.Patient had to endure painful and protracted recovery.Patient has also developed atrial fibrillation.Patient also require additional surgery for the removal of sternal wiring.No further patient information received medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABRE VENOUS SELF-EXPANDING STENT SYSTEM
Common Device Name
STENT, ILIAC VEIN
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19462788
Report Number2183870-2024-00180
Device Sequence Number7926372
Product Code QAN
UDI-Device Identifier00643169796157
UDI-Public(01)00643169796157(17)250218(10)B341265
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P200026
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/18/2025
Device Catalogue NumberAB9U10040090
Device Lot NumberB341265
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/07/2024
Supplement Date Received by Manufacturer05/07/2025
08/21/2025
Initial Report FDA Received Date06/04/2024
Supplement Report FDA Received Date05/30/2025
09/12/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/19/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age37 YR
Patient SexFemale
Patient Weight64 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-